491 related articles for article (PubMed ID: 19447674)
1. GP5+/6+ SYBR Green methodology for simultaneous screening and quantification of human papillomavirus.
de Araujo MR; De Marco L; Santos CF; Rubira-Bullen IR; Ronco G; Pennini I; Vizzini L; Merletti F; Gillio-Tos A
J Clin Virol; 2009 Jun; 45(2):90-5. PubMed ID: 19447674
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits.
Gillio-Tos A; De Marco L; Ghisetti V; Snijders PJ; Segnan N; Ronco G; Merletti F
J Clin Virol; 2006 Jun; 36(2):126-32. PubMed ID: 16624614
[TBL] [Abstract][Full Text] [Related]
3. Universal ProbeLibrary based real-time PCR assay for detection and confirmation of human papillomavirus genotype 52 infections.
Kocjan BJ; Poljak M; Seme K
J Virol Methods; 2010 Feb; 163(2):492-4. PubMed ID: 19883693
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set.
Jones J; Powell NG; Tristram A; Fiander AN; Hibbitts S
J Clin Virol; 2009 Jun; 45(2):100-4. PubMed ID: 19394266
[TBL] [Abstract][Full Text] [Related]
5. Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types.
Schmitz M; Scheungraber C; Herrmann J; Teller K; Gajda M; Runnebaum IB; Dürst M
J Clin Virol; 2009 Apr; 44(4):302-7. PubMed ID: 19223232
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems.
Payan C; Ducancelle A; Aboubaker MH; Caer J; Tapia M; Chauvin A; Peyronnet D; Le Hen E; Arab Z; Legrand MC; Tran A; Postec E; Tourmen F; Avenel M; Malbois C; De Brux MA; Descamps P; Lunel F
J Clin Microbiol; 2007 Mar; 45(3):897-901. PubMed ID: 17229868
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric GP5+/6+ PCR and hybridization with fluorescence polarization assay of 15 human papillomavirus genotypes in clinical samples.
Ju Z; Yane G; Ding L; Guowu Y; Yanhai G; Yonglan L
J Clin Virol; 2009 Feb; 44(2):106-10. PubMed ID: 19144564
[TBL] [Abstract][Full Text] [Related]
8. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers.
Schmitt M; Dondog B; Waterboer T; Pawlita M
J Clin Microbiol; 2008 Mar; 46(3):1050-9. PubMed ID: 18199790
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR.
Lin CY; Chao A; Yang YC; Chou HH; Ho CM; Lin RW; Chang TC; Chiou JY; Chao FY; Wang KL; Chien TY; Hsueh S; Huang CC; Chen CJ; Lai CH
J Clin Virol; 2008 Aug; 42(4):361-7. PubMed ID: 18455959
[TBL] [Abstract][Full Text] [Related]
10. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets.
Remmerbach TW; Brinckmann UG; Hemprich A; Chekol M; Kühndel K; Liebert UG
J Clin Virol; 2004 Aug; 30(4):302-8. PubMed ID: 15163418
[TBL] [Abstract][Full Text] [Related]
11. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
12. High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women.
Prétet JL; Dalstein V; Monnier-Benoit S; Delpeut S; Mougin C
J Clin Virol; 2004 Oct; 31(2):140-7. PubMed ID: 15364271
[TBL] [Abstract][Full Text] [Related]
13. A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV 16 and 18 in cervical scrapes after GP5+/6+ PCR.
Jacobs MV; van den Brule AJ; Snijders PJ; Helmerhorst TJ; Meijer CJ; Walboomers JM
J Med Virol; 1996 Jul; 49(3):223-9. PubMed ID: 8818969
[TBL] [Abstract][Full Text] [Related]
14. High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups.
Leo E; Venturoli S; Cricca M; Musiani M; Zerbini M
J Clin Virol; 2009 Aug; 45(4):304-10. PubMed ID: 19473874
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.
Hesselink AT; Bulkmans NW; Berkhof J; Lorincz AT; Meijer CJ; Snijders PJ
J Clin Microbiol; 2006 Oct; 44(10):3680-5. PubMed ID: 17021097
[TBL] [Abstract][Full Text] [Related]
16. A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings.
Jacobs MV; Walboomers JM; van Beek J; Voorhorst FJ; Verheijen RH; Meijer CJ; van den Brule AJ; Helmerhorst TJ; Snijders PJ
Br J Cancer; 1999 Sep; 81(1):114-21. PubMed ID: 10487621
[TBL] [Abstract][Full Text] [Related]
17. Confirmation and quantitation of human papillomavirus type 52 by Roche Linear Array using HPV52-specific TaqMan E6/E7 quantitative real-time PCR.
Marks M; Gupta SB; Liaw KL; Kim E; Tadesse A; Coutlee F; Sriplienchan S; Celentano DD; Gravitt PE
J Virol Methods; 2009 Mar; 156(1-2):152-6. PubMed ID: 19022296
[TBL] [Abstract][Full Text] [Related]
18. Automated extraction and quantitation of oncogenic HPV genotypes from cervical samples by a real-time PCR-based system.
Broccolo F; Cocuzza CE
J Virol Methods; 2008 Mar; 148(1-2):48-57. PubMed ID: 18053585
[TBL] [Abstract][Full Text] [Related]
19. HPV molecular assays: defining analytical and clinical performance characteristics for cervical cytology specimens.
Shen-Gunther J; Yu X
Gynecol Oncol; 2011 Nov; 123(2):263-71. PubMed ID: 21839499
[TBL] [Abstract][Full Text] [Related]
20. HPV DNA detection and typing in cervical scrapes.
Snijders PJ; van den Brule AJ; Jacobs MV; Pol RP; Meijer CJ
Methods Mol Med; 2005; 119():101-14. PubMed ID: 16350400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
